Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Armata Pharmaceuticals (ARMP) has a market cap of $79.241 million USD. According to our data, Armata Pharmaceuticals is ranked No.7863 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $79.24 M |
18.38%
|
| Dec 31, 2024 | $66.94 M |
-42.90%
|
| Dec 29, 2023 | $0.12 B |
161.29%
|
| Dec 30, 2022 | $44.87 M |
-77.37%
|
| Dec 31, 2021 | $0.20 B |
83.89%
|
| Dec 31, 2020 | $0.11 B |
-8.31%
|
| Dec 31, 2019 | $0.12 B |
10.54%
|
| Dec 31, 2018 | $0.11 B |
-79.21%
|
| Dec 29, 2017 | $0.51 B |
-77.05%
|
| Dec 30, 2016 | $2.23 B |
-88.94%
|
| Dec 31, 2015 | $20.16 B |
-62.10%
|
| Dec 31, 2014 | $53.19 B |
-58.00%
|
| Dec 31, 2013 | $126.64 B |
177.78%
|
| Dec 31, 2012 | $45.59 B |
63.64%
|
| Dec 30, 2011 | $27.86 B |
-69.44%
|
| Dec 31, 2010 | $91.18 B |
28.57%
|
| Dec 31, 2009 | $70.92 B |
27.27%
|
| Dec 31, 2008 | $55.72 B |
-85.71%
|
| Dec 31, 2007 | $390.05 B |
-71.32%
|
| Dec 29, 2006 | $1.360 T |
9.59%
|
| Dec 30, 2005 | $1.241 T |
-68.39%
|
| Dec 31, 2004 | $3.926 T |
-29.22%
|
| Dec 31, 2003 | $5.547 T |
447.50%
|
| Dec 31, 2002 | $1.013 T |
-85.24%
|
| Dec 31, 2001 | $6.864 T |
-59.48%
|
| Dec 29, 2000 | $16.938 T |
69.84%
|
| Dec 31, 1999 | $9.973 T |
200.00%
|
| Dec 31, 1998 | $3.324 T |
-50.00%
|
| Dec 31, 1997 | $6.649 T |
-41.67%
|
| Dec 31, 1996 | $11.398 T |
-20.00%
|
| Dec 29, 1995 | $14.247 T |
7.14%
|
| Dec 30, 1994 | $13.297 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
| Market Cap | = | ARMP Stock Price | * | ARMP Shares Outstanding |
| = | $2.19 | * | 36.18 M | |
| = | $79.24 M |